Literature DB >> 28957946

Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia.

Laura Yunes-Medina1, Julianne Feola, Gail V W Johnson.   

Abstract

The multifunctional protein transglutaminase 2 (TG2) has been widely implicated as a modulator of cellular viability. Specifically, TG2 expression is beneficial to neuronal survival following an ischemic injury, whereas the opposite is true in astrocytes. Furthermore, its role in mediating cell death and survival processes has been suggested to be dependent on its subcellular localization. Therefore, the aim of this study was to examine the subcellular localization patterns of neuronal and astrocytic TG2 in ischemia-relevant conditions. We found that nuclear levels of TG2 were significantly increased in neurons, but reduced in astrocytes, in response to hypoxia. In addition, there were no changes in extracellular TG2 in astrocytes exposed to hypoxia. Thus, these findings demonstrate a difference in the subcellular localization pattern of TG2 in neurons and astrocytes in ischemia-relevant conditions and provide further avenues for investigation into the role of TG2 in mediating cellular viability.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28957946      PMCID: PMC5685886          DOI: 10.1097/WNR.0000000000000895

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  34 in total

1.  Transglutaminase 2 protects against ischemic stroke.

Authors:  A J Filiano; J Tucholski; P J Dolan; G Colak; G V W Johnson
Journal:  Neurobiol Dis       Date:  2010-05-06       Impact factor: 5.996

Review 2.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

3.  Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.

Authors:  Julianne Feola; Alan Barton; Abdullah Akbar; Jeffrey Keillor; Gail V W Johnson
Journal:  Brain Res       Date:  2017-05-15       Impact factor: 3.252

4.  Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.

Authors:  Alina Monteagudo; Changyi Ji; Abdullah Akbar; Jeffrey W Keillor; Gail V W Johnson
Journal:  Biochem Biophys Res Commun       Date:  2016-11-27       Impact factor: 3.575

5.  Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?

Authors:  Miriam E van Strien; Benjamin Drukarch; John G Bol; Paul van der Valk; Jack van Horssen; Wouter H Gerritsen; John J Breve; Anne-Marie van Dam
Journal:  Brain Pathol       Date:  2010-08-20       Impact factor: 6.508

Review 6.  Vascular events after spinal cord injury: contribution to secondary pathogenesis.

Authors:  A E Mautes; M R Weinzierl; F Donovan; L J Noble
Journal:  Phys Ther       Date:  2000-07

7.  Transglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubules.

Authors:  Yuyu Song; Laura L Kirkpatrick; Alexander B Schilling; Donald L Helseth; Nicolas Chabot; Jeffrey W Keillor; Gail V W Johnson; Scott T Brady
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

8.  Cell death in primary cultures of mouse neurons and astrocytes during exposure to and 'recovery' from hypoxia, substrate deprivation and simulated ischemia.

Authors:  E Sochocka; B H Juurlink; W E Code; V Hertz; L Peng; L Hertz
Journal:  Brain Res       Date:  1994-02-28       Impact factor: 3.252

9.  Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.

Authors:  Bakhtiyor Yakubov; Bhadrani Chelladurai; Jordan Schmitt; Robert Emerson; John J Turchi; Daniela Matei
Journal:  Neoplasia       Date:  2013-06       Impact factor: 5.715

10.  Characterization of distinct sub-cellular location of transglutaminase type II: changes in intracellular distribution in physiological and pathological states.

Authors:  Mauro Piacentini; Manuela D'Eletto; Maria Grazia Farrace; Carlo Rodolfo; Franca Del Nonno; Giuseppe Ippolito; Laura Falasca
Journal:  Cell Tissue Res       Date:  2014-09-11       Impact factor: 5.249

View more
  3 in total

Review 1.  Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.

Authors:  Breandan R Quinn; Laura Yunes-Medina; Gail V W Johnson
Journal:  J Neurosci Res       Date:  2018-03-23       Impact factor: 4.164

2.  Depletion of transglutaminase 2 in neurons alters expression of extracellular matrix and signal transduction genes and compromises cell viability.

Authors:  Laura Yunes-Medina; Alex Paciorkowski; Yan Nuzbrokh; Gail V W Johnson
Journal:  Mol Cell Neurosci       Date:  2017-11-29       Impact factor: 4.314

3.  Depletion of astrocytic transglutaminase 2 improves injury outcomes.

Authors:  Alina Monteagudo; Julianne Feola; Heather Natola; Changyi Ji; Christoph Pröschel; Gail V W Johnson
Journal:  Mol Cell Neurosci       Date:  2018-06-30       Impact factor: 4.314

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.